1． Amason A C,Shrader R C, Tompson G H. Newness and novelty: Relating top management teamcomposition to new venture performance[J]. Journal of Business Venturing, 2006,21(1): 125-148.

2． Hand, J. R. M.2007. Determinants of the round-to-round returns to pre-IPO venture capitalinvestments in US biotechnology companies. Journal of Business Venturing, 22:1-28.

3． Arthurs, J.D., & Busenitz, L. W. 2006. Dynamic capabilities and venture performance:The effects of venture capitalists. Journal of Business Venturing, 21: 195-215.

4． Daily, C. M.,Certo, S. T., & Dalton, D. R. 2005. Investment bankers and IPO pricing:Does prospectus information matter? Journal of Business Venturing, 20: 93-111.

5． Florin, J.2005. Is venture capital worth it? Effects on firm performance and founderreturns. Journal of Business Venturing, 20: 113-135.

6． Mudambi, R.,& Treichel, M. Z. 2005. Cash crisis in newly public Internet-based firms:An empirical analysis. Journal of Business Venturing, 20: 543-571.

7． Janney, J. J.,& Folta, T. B. 2003. Signaling through private equity placements and itsimpact on the valuation of biotechnology firms. Journal of Business Venturing,18: 361-380.